• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血小板活化因子在大鼠腹膜多形核白细胞中的高亲和力受体结合

High affinity receptor binding of platelet-activating factor in rat peritoneal polymorphonuclear leukocytes.

作者信息

Hwang S B

机构信息

Merck Sharp & Dohme Research Laboratories, Department of Biochemical Regulation, Rahway, NJ 07065-0900.

出版信息

Eur J Pharmacol. 1991 Apr 17;196(2):169-75. doi: 10.1016/0014-2999(91)90424-o.

DOI:10.1016/0014-2999(91)90424-o
PMID:1651872
Abstract

Rat peritoneal polymorphonuclear leukocytes (PMNs) showed a single class of high affinity binding sites for platelet-activating factor (PAF) with an equilibrium dissociation constant (KD) of 4.74 (+/- 2.59) nM. Each cell contained 2.79 (+/- 1.40) x 10(4) receptors. In the isolated membranes at pH 7.0 in 10 mM MgCl2, 10 mM Tris and 0.25% bovine serum albumin, the KD value was 0.61 (+/- 0.1) nM, which is roughly identical to the KD values reported previously for various membrane systems under identical ionic conditions. The receptors were highly specific for PAF. Several receptor antagonists that are reported to inhibit the binding of [3H]PAF and the PAF-induced function in platelets could fully displace the binding. The biologically inactive enantiomer (enantio-C16-PAF), a PAF analog, azido-PAF, and an indene derivative of the PAF receptor antagonist, L-651,142, had different potencies to inhibit [3H]PAF binding to rat and human PMN membranes. L-652,731, a tetrahydrofuran analog of the PAF receptor antagonist was about 10 times more potent to inhibit the binding in rat liver tissues than in rat PMNs. These results suggest that PAF receptors on human and rat PMNs are not identical and that PAF receptor subtypes may exist in rat liver and PMNs.

摘要

大鼠腹膜多形核白细胞(PMNs)显示出一类对血小板活化因子(PAF)具有高亲和力的结合位点,其平衡解离常数(KD)为4.74(±2.59)nM。每个细胞含有2.79(±1.40)×10⁴个受体。在10 mM MgCl₂、10 mM Tris和0.25%牛血清白蛋白存在下,pH 7.0的分离膜中,KD值为0.61(±0.1)nM,这与先前在相同离子条件下报道的各种膜系统的KD值大致相同。这些受体对PAF具有高度特异性。据报道,几种能抑制[³H]PAF结合及血小板中PAF诱导功能的受体拮抗剂可完全取代结合。生物活性无活性对映体(对映体-C16-PAF)、PAF类似物叠氮基-PAF以及PAF受体拮抗剂L-651,142的茚衍生物,在抑制[³H]PAF与大鼠和人PMN膜结合方面具有不同的效力。PAF受体拮抗剂的四氢呋喃类似物L-652,731在抑制大鼠肝组织中结合方面的效力比在大鼠PMN中约强10倍。这些结果表明,人和大鼠PMN上的PAF受体并不相同,并且PAF受体亚型可能存在于大鼠肝脏和PMN中。

相似文献

1
High affinity receptor binding of platelet-activating factor in rat peritoneal polymorphonuclear leukocytes.血小板活化因子在大鼠腹膜多形核白细胞中的高亲和力受体结合
Eur J Pharmacol. 1991 Apr 17;196(2):169-75. doi: 10.1016/0014-2999(91)90424-o.
2
Characterization of platelet-activating factor (PAF) receptor by specific binding of [3H]L-659,989, a PAF receptor antagonist, to rabbit platelet membranes: possible multiple conformational states of a single type of PAF receptors.通过血小板活化因子(PAF)受体拮抗剂[3H]L-659,989与兔血小板膜的特异性结合对PAF受体进行表征:单一类型PAF受体可能存在多种构象状态
Mol Pharmacol. 1989 Jan;35(1):48-58.
3
Identification of a second putative receptor of platelet-activating factor from human polymorphonuclear leukocytes.从人多形核白细胞中鉴定血小板活化因子的第二种假定受体。
J Biol Chem. 1988 Mar 5;263(7):3225-33.
4
Pharmacologic characterization of the rabbit neutrophil receptor for platelet-activating factor.兔血小板活化因子中性粒细胞受体的药理学特性
Proc Soc Exp Biol Med. 1990 Nov;195(2):247-54. doi: 10.3181/00379727-195-43143.
5
[3H]52770 RP, a platelet-activating factor receptor antagonist, and tritiated platelet-activating factor label a common specific binding site in human polymorphonuclear leukocytes.[3H]52770 RP,一种血小板激活因子受体拮抗剂,与氚标记的血小板激活因子标记人多形核白细胞中的一个共同特异性结合位点。
J Pharmacol Exp Ther. 1988 Feb;244(2):709-15.
6
L-659,989: a useful probe in the detection of multiple conformational states of PAF receptors.
Lipids. 1991 Dec;26(12):1148-53. doi: 10.1007/BF02536520.
7
MK 287: a potent, specific, and orally active receptor antagonist of platelet-activating factor.MK 287:一种强效、特异性且口服有效的血小板活化因子受体拮抗剂。
J Lipid Mediat. 1993 Jun;7(2):115-34.
8
Evidence for the existence and ionic modulation of platelet-activating factor receptors mediating degranulatory responses in human polymorphonuclear leukocytes.介导人类多形核白细胞脱颗粒反应的血小板活化因子受体的存在及离子调节的证据。
J Pharmacol Exp Ther. 1989 Jul;250(1):293-300.
9
Specific binding of [3H]dihydrokadsurenone to rabbit platelet membranes and its inhibition by the receptor agonists and antagonists of platelet-activating factor.[3H]二氢卡苏烯酮与兔血小板膜的特异性结合及其受血小板活化因子受体激动剂和拮抗剂的抑制作用。
J Biol Chem. 1986 Oct 15;261(29):13720-6.
10
Specific receptor sites for platelet activating factor on rat liver plasma membranes.大鼠肝细胞膜上血小板活化因子的特异性受体位点。
Arch Biochem Biophys. 1987 Sep;257(2):339-44. doi: 10.1016/0003-9861(87)90574-1.

引用本文的文献

1
Impaired anaphylactic responses with intact sensitivity to endotoxin in mice lacking a platelet-activating factor receptor.
J Exp Med. 1998 Jun 1;187(11):1779-88. doi: 10.1084/jem.187.11.1779.
2
Structural and (patho)physiological diversity of PAF.血小板活化因子的结构与(病理)生理多样性。
Clin Rev Allergy. 1994 Winter;12(4):329-59. doi: 10.1007/BF02802299.